PAR NOTICE OF RELEASE OF ESCROWED SECURITIES 14/09/22 download Created with Sketch. 265.06KB Share PAR Application for quotation of securities - PAR 14/09/22 download Created with Sketch. 26.25KB Share PAR Successful Completion of Entitlement Offer 13/09/22 PRICE SENSITIVE download Created with Sketch. 252.04KB Share PAR Paradigm Appoints Interim Company Secretary 30/08/22 download Created with Sketch. 60.4KB Share PAR Appendix 4G and 2022 Corporate Governance Statement 26/08/22 download Created with Sketch. 524.74KB Share PAR 2022 Annual Report and Appendix 4E 26/08/22 PRICE SENSITIVE download Created with Sketch. 3.06MB Share PAR Becoming a substantial holder 23/08/22 download Created with Sketch. 5.38MB Share PAR Cleansing Notice 22/08/22 download Created with Sketch. 259.51KB Share PAR PAR Non-Renounceable Rights Issue Offer Booklet 22/08/22 PRICE SENSITIVE download Created with Sketch. 491.7KB Share PAR Ineligible Shareholder Letter 19/08/22 download Created with Sketch. 110.79KB Share PAR Cleansing Notice 19/08/22 download Created with Sketch. 229.34KB Share PAR Application for quotation of securities - PAR 19/08/22 download Created with Sketch. 26.52KB Share PAR Letter to Optionholders 15/08/22 download Created with Sketch. 259.03KB Share PAR Cleansing Notice 15/08/22 download Created with Sketch. 253.46KB Share PAR Proposed issue of securities - PAR 15/08/22 download Created with Sketch. 38.62KB Share PAR Investor Presentation - $66m Capital Raise 15/08/22 PRICE SENSITIVE download Created with Sketch. 17.45MB Share PAR Paradigm Launches $66M Capital Raising 15/08/22 PRICE SENSITIVE download Created with Sketch. 109.35KB Share PAR Trading Halt 11/08/22 PRICE SENSITIVE download Created with Sketch. 215.01KB Share PAR Paradigm provides MPS Clinical Program update 08/08/22 PRICE SENSITIVE download Created with Sketch. 125.92KB Share PAR Quarterly Update and Appendix 4C - quarterly 28/07/22 PRICE SENSITIVE download Created with Sketch. 361.1KB Share PAR Investor Webinar 15/07/22 download Created with Sketch. 84.75KB Share PAR Notification of cessation of securities - PAR 14/07/22 download Created with Sketch. 26.1KB Share PAR Paradigm Partners with NFL Alumni Health for OA Program 13/07/22 PRICE SENSITIVE download Created with Sketch. 120.7KB Share PAR Application for quotation of securities - PAR 12/07/22 download Created with Sketch. 25.1KB Share PAR Notification regarding unquoted securities - PAR 07/07/22 download Created with Sketch. 37.95KB Share PAR Paradigm reports global progress in phase 3 study 06/07/22 PRICE SENSITIVE download Created with Sketch. 93.55KB Share PAR 100% Recruitment in Synovial Fluid Biomarker Trial 01/07/22 PRICE SENSITIVE download Created with Sketch. 105.27KB Share PAR Paradigm Reports Australian Patent Acceptance 30/06/22 PRICE SENSITIVE download Created with Sketch. 93.91KB Share PAR NOTICE OF RELEASE OF ESCROWED SECURITIES 29/06/22 download Created with Sketch. 234.96KB Share PAR Paradigm Receives $8.2m R&D Tax Incentive Refund 07/06/22 PRICE SENSITIVE download Created with Sketch. 457.65KB Share PAR Paradigm Appoints Experienced US-Based CEO 30/05/22 PRICE SENSITIVE download Created with Sketch. 679KB Share PAR Quarterly Update and Appendix 4C - quarterly 29/04/22 PRICE SENSITIVE download Created with Sketch. 324.88KB Share PAR Paradigm Doses First US Subjects under Phase 3 trial 28/04/22 PRICE SENSITIVE download Created with Sketch. 103.61KB Share PAR FDA Grants Paradigm Fast Track Designation For OA 12/04/22 PRICE SENSITIVE download Created with Sketch. 115.14KB Share PAR UK ethics and regulatory approval for Phase 3 study 17/03/22 download Created with Sketch. 97.42KB Share PAR Change in substantial holding 09/03/22 download Created with Sketch. 268.16KB Share PAR Change of Director's Interest Notice 09/03/22 download Created with Sketch. 178.18KB Share PAR Clarification of recent analyst report on Patent Protection 09/03/22 PRICE SENSITIVE download Created with Sketch. 124.99KB Share PAR S&P DJI Announces March 2022 Quarterly Rebalance 04/03/22 PRICE SENSITIVE download Created with Sketch. 175.5KB Share PAR Amended Appendix 4D 24/02/22 download Created with Sketch. 227.69KB Share PAR Paradigm 1HY22 Key Activity Highlights 24/02/22 PRICE SENSITIVE download Created with Sketch. 102.41KB Share PAR Half Yearly Report and Accounts 24/02/22 PRICE SENSITIVE download Created with Sketch. 3.23MB Share PAR PPS a new adjunct therapy treatment for patients with MPS VI 11/02/22 download Created with Sketch. 1.78MB Share PAR Change of Director's Interest Notice 01/02/22 download Created with Sketch. 169.31KB Share PAR Cleansing Notice 01/02/22 download Created with Sketch. 174.68KB Share PAR Notification regarding unquoted securities - PAR 01/02/22 download Created with Sketch. 35.98KB Share PAR Quarterly Update and Appendix 4C - quarterly 31/01/22 PRICE SENSITIVE download Created with Sketch. 334.43KB Share PAR Results of Meeting 25/01/22 download Created with Sketch. 233.28KB Share PAR Paradigm AGM Presentation 25/01/22 download Created with Sketch. 7.11MB Share PAR PARADIGM TREATS FIRST SUBJECTS IN PHASE 3 TRIAL OF ZILOSUL 13/01/22 PRICE SENSITIVE download Created with Sketch. 116.32KB Share PAR Paradigm to present at the J.P Morgan Healthcare Conference 12/01/22 download Created with Sketch. 15.3MB Share PAR Notice of Annual General Meeting/Proxy Form 24/12/21 download Created with Sketch. 926.58KB Share PAR PAR REPORTS POSTIVE TOPLINE RESULTS IN HEART FAILURE MODEL 16/12/21 PRICE SENSITIVE download Created with Sketch. 178.5KB Share PAR Paradigm Presentation for Investor Webinar 02/12/21 download Created with Sketch. 58.84KB Share PAR Paradigm Investor Webinar 30/11/21 download Created with Sketch. 59.91KB Share PAR Application for quotation of securities - PAR 24/11/21 download Created with Sketch. 24.33KB Share PAR Preliminary Results from Phase 2 MPS I Study 23/11/21 PRICE SENSITIVE download Created with Sketch. 100.21KB Share PAR Paradigm CEO Paul Rennie to transition to Non-Exec Chairman 22/11/21 PRICE SENSITIVE download Created with Sketch. 73.13KB Share PAR Paradigm welcomes Dr Reiter from bene pharmaChem to the team 18/11/21 download Created with Sketch. 84.43KB Share PAR NOTICE OF RELEASE OF ESCROWED SECURITIES 11/11/21 download Created with Sketch. 155.26KB Share PAR Paradigm Presentation to Bell Potter Healthcare Conference 09/11/21 download Created with Sketch. 608.22KB Share PAR Global Market Research indicates price for Zilosu 08/11/21 download Created with Sketch. 109.93KB Share PAR PARADIGM CLEARED FOR PHASE 3 TRIAL BY US FDA 03/11/21 PRICE SENSITIVE download Created with Sketch. 119.05KB Share PAR Trading Halt 01/11/21 PRICE SENSITIVE download Created with Sketch. 587.27KB Share PAR Date of Annual General Meeting 29/10/21 download Created with Sketch. 66.91KB Share PAR Quarterly Update and Appendix 4C - quarterly 28/10/21 PRICE SENSITIVE download Created with Sketch. 331.59KB Share PAR Phase 2 Synovial Fluid Biomarker Study Update 26/10/21 PRICE SENSITIVE download Created with Sketch. 133.91KB Share PAR POSITIVE TOP-LINE RESULTS FROM PRECLINICAL STUDY IN ARDS 13/10/21 PRICE SENSITIVE download Created with Sketch. 1.52MB Share PAR FIRST MPS-VI PATIENT DOSED UNDER PHASE 2 TRIAL IN BRAZIL 30/09/21 PRICE SENSITIVE download Created with Sketch. 106.69KB Share PAR PARADIGM RECEIVES FEEDBACK FROM US FDA ON IND SUBMISSION 27/09/21 PRICE SENSITIVE download Created with Sketch. 78.02KB Share PAR AUS ETHICS APPROVAL RECEIVED FOR PHASE 3 TRIAL 24/09/21 PRICE SENSITIVE download Created with Sketch. 81.65KB Share PAR Cleansing Notice 17/09/21 download Created with Sketch. 161.44KB Share PAR Notification regarding unquoted securities - PAR 17/09/21 download Created with Sketch. 33.99KB Share PAR CHIKV study data published in Peer-Reviewed Journal 13/09/21 download Created with Sketch. 2.77MB Share PAR Appendix 4G and 2021 Corporate Governance Statement 27/08/21 download Created with Sketch. 430.31KB Share PAR 2021 Annual Report and Appendix 4E 27/08/21 PRICE SENSITIVE download Created with Sketch. 2.48MB Share PAR PARADIGM REPORTS IND APPLICATION UPDATE 03/08/21 PRICE SENSITIVE download Created with Sketch. 82.91KB Share PAR Trading Halt 30/07/21 PRICE SENSITIVE download Created with Sketch. 587.14KB Share PAR Quarterly Update and Appendix 4C - quarterly 29/07/21 PRICE SENSITIVE download Created with Sketch. 282.04KB Share PAR Application for quotation of securities - PAR 19/07/21 download Created with Sketch. 24.29KB Share PAR Notification of cessation of securities - PAR 14/07/21 download Created with Sketch. 23.55KB Share PAR NOTICE OF RELEASE OF ESCROWED SECURITIES 09/07/21 download Created with Sketch. 155.69KB Share PAR PARADIGM SUBMITS RESPONSES TO US FDA QUESTIONS 30/06/21 PRICE SENSITIVE download Created with Sketch. 73.14KB Share PAR PARADIGM RECEIVES KEY REGULATORY APPROVALS FOR MPS VI STUDY 18/06/21 PRICE SENSITIVE download Created with Sketch. 94.78KB Share PAR IND QUESTIONS RECEIVED FROM US FDA 25/05/21 PRICE SENSITIVE download Created with Sketch. 61.58KB Share PAR Cleansing Notice and Appendix 2A 21/05/21 download Created with Sketch. 422.24KB Share PAR PARADIGM ACHIEVES FIRST REVENUE 19/05/21 PRICE SENSITIVE download Created with Sketch. 171.36KB Share PAR Cleansing Notice and Appendix 2A 13/05/21 download Created with Sketch. 422.48KB Share PAR Paradigm to Present at Truist Securities Life Sciences Summi 03/05/21 download Created with Sketch. 74.38KB Share PAR Quarterly Update and Appendix 4C - quarterly 30/04/21 PRICE SENSITIVE download Created with Sketch. 280.87KB Share PAR PARADIGM PROVIDES IND APPLICATION UPDATE 26/04/21 PRICE SENSITIVE download Created with Sketch. 66.89KB Share PAR Cleansing Notice and Appendix 2A 15/04/21 download Created with Sketch. 423.91KB Share PAR Paradigm doses first participant in Synovial Fluid Trial 14/04/21 PRICE SENSITIVE download Created with Sketch. 132.05KB Share PAR Paradigm and Bene Execute New Collaboration Agreement 31/03/21 PRICE SENSITIVE download Created with Sketch. 96.66KB Share PAR Paradigm delivers IND to US FDA for Pivotal OA Program 26/03/21 PRICE SENSITIVE download Created with Sketch. 145.81KB Share PAR PHASE 2 RRV DATA PUBBLISHED IN PEER-REVIEWED JOURNAL 18/03/21 download Created with Sketch. 125.19KB Share PAR Initial Director's Interest Notice 26/02/21 download Created with Sketch. 151.79KB Share PAR Half Yearly Report and Accounts 24/02/21 PRICE SENSITIVE download Created with Sketch. 694.58KB Share PAR Paradigm Receives $3.38m R&D Tax Incentive Refund 23/02/21 download Created with Sketch. 65.09KB Share PAR Ethics Approval Received for Synovial Fluid Biomarker Study 18/02/21 download Created with Sketch. 260.72KB Share
(20min delay)
